Ocular microvascular alteration in Sjögren’s syndrome treated with hydroxychloroquine: an OCTA clinical study

BACKGROUND: Sjögren’s syndrome (SjS) is a rare autoimmune disease, and despite our knowledge of SjS, we still lack effective treatments. Chloroquine drugs used to treat autoimmune diseases are still the primary medicine for SjS but increase the risk of chloroquine retinopathy. OBJECTIVES: The object...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chao, Zou, Jie, Ge, Qian-Min, Liao, Xu-Lin, Pan, Yi-Cong, Wu, Jie-Li, Su, Ting, Zhang, Li-Juan, Liang, Rong-Bin, Shao, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Artificial Intelligence related Optical Bioimaging markers in inflammatory and degenerative diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126603/
https://www.ncbi.nlm.nih.gov/pubmed/37114215
http://dx.doi.org/10.1177/20406223231164498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126603/
https://www.ncbi.nlm.nih.gov/pubmed/37114215
http://dx.doi.org/10.1177/20406223231164498

Ejemplares similares